Cargando…
Inhibition of miR-182-5p Targets FGF9 to Alleviate Osteoarthritis
BACKGROUND: The pathogenesis of osteoarthritis (OA) is complex and there is no specific drug for treatment. The aim of this study was to identify the molecular targets of OA therapy, focusing on the expression and biological functions of miR-182-5p and its target genes in OA. METHODS: miR-182-5p and...
Autores principales: | Sun, Yang, Su, Sanmao, Li, Mengjun, Deng, Ang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076120/ https://www.ncbi.nlm.nih.gov/pubmed/37035017 http://dx.doi.org/10.1155/2023/5911546 |
Ejemplares similares
-
Effect of lentivirus-mediated miR-182 targeting FGF9 on hallux valgus
por: Zhang, Wei-Lin, et al.
Publicado: (2021) -
Inhibiting miR-182-3p Alleviates Gestational Diabetes Mellitus by Improving Insulin Resistance in Skeletal Muscle
por: Rao, Jinghong, et al.
Publicado: (2022) -
miR-182 inhibits Schwann cell proliferation and migration by targeting FGF9 and NTM, respectively at an early stage following sciatic nerve injury
por: Yu, Bin, et al.
Publicado: (2012) -
Clinical Significance of miR-183-3p and miR-182-5p in NSCLC and Their Correlation
por: Zhang, Tianxiang, et al.
Publicado: (2021) -
miR-182-5p attenuates
Schistosoma japonicum-induced hepatic fibrosis by targeting tristetraprolin
: miR-182-5p attenuates hepatic fibrosis
por: Zhao, Xuejun, et al.
Publicado: (2022)